Search

Your search keyword '"Handschumacher RE"' showing total 154 results

Search Constraints

Start Over You searched for: Author "Handschumacher RE" Remove constraint Author: "Handschumacher RE"
154 results on '"Handschumacher RE"'

Search Results

2. Bacterial preparation of orotidine-5'-phosphate and uridine-5'-phosphate

Catalog

Books, media, physical & digital resources

5. Identification of two calcineurin B-binding proteins: tubulin and heat shock protein 60.

6. Homeostatic control of uridine and the role of uridine phosphorylase: a biological and clinical update.

7. Uridine phosphorylase association with vimentin. Intracellular distribution and localization.

8. Genomic structure, chromosomal mapping, and promoter region analysis of murine uridine phosphorylase gene.

9. beta-alanine and alpha-fluoro-beta-alanine concentrative transport in rat hepatocytes is mediated by GABA transporter GAT-2.

10. Expression, characterization, and detection of human uridine phosphorylase and identification of variant uridine phosphorolytic activity in selected human tumors.

11. Discrete roles of hepatocytes and nonparenchymal cells in uridine catabolism as a component of its homeostasis.

12. Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor.

13. HIV protease substrate conformation: modulation by cyclophilin A.

14. Pharmacokinetic and phase I trial of intraperitoneal carboplatin and cyclosporine in refractory ovarian cancer patients.

15. Regulation of the nuclear factor of activated T cells in stably transfected Jurkat cell clones.

16. The cyclosporin A-binding immunophilin CyP-40 and the FK506-binding immunophilin hsp56 bind to a common site on hsp90 and exist in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor.

17. Tamoxifen induces Na+ -dependent uridine transport and dome formation in a human breast tumor cell line.

18. Cyclosporin A potentiates the dexamethasone-induced mouse mammary tumor virus-chloramphenicol acetyltransferase activity in LMCAT cells: a possible role for different heat shock protein-binding immunophilins in glucocorticosteroid receptor-mediated gene expression.

19. Cyclophilin-40: evidence for a dimeric complex with hsp90.

20. Expression of human cyclophilin-40 and the effect of the His141-->Trp mutation on catalysis and cyclosporin A binding.

21. Toxoplasma gondii tachyzoites possess an unusual plasma membrane adenosine transporter.

22. Effect of clinically modeled regimens on the growth response and development of resistance in human colon carcinoma cell lines.

23. Aberrant cell cycle inhibition pattern in human colon carcinoma cell lines after exposure to 5-fluorouracil.

24. Concentrative transport of adenosine in murine splenocytes: limitation by an ecto-adenosine deaminase.

25. Differentiation of HL-60 cells by dimethylsulfoxide activates a Na(+)-dependent nucleoside transport system.

26. Isolation, cDNA sequences, and biochemical characterization of the major cyclosporin-binding proteins of Toxoplasma gondii.

27. Specific interaction of the cyclophilin-cyclosporin complex with the B subunit of calcineurin.

28. Cyclophilin-40, a protein with homology to the P59 component of the steroid receptor complex. Cloning of the cDNA and further characterization.

29. Autoantibodies against cyclophilin in systemic lupus erythematosus and Lyme disease.

30. Immunofluorescent localization and immunochemical determination of cyclophilin-A with specific rabbit antisera.

31. Leukocyte chemotactic activity of cyclophilin.

32. Immunity, microbial pathogenesis, and immunophilins: finding the keys, now where are the locks?

33. Isolation and partial characterization of membrane-associated cyclophilin and a related 22-kDa glycoprotein.

34. Brequinar potentiates 5-fluorouracil antitumor activity in a murine model colon 38 tumor by tissue-specific modulation of uridine nucleotide pools.

35. Isolation and characterization of a 40-kDa cyclophilin-related protein.

36. Inhibition by pertussis toxin of the activation of Na(+)-dependent uridine transport in dimethyl-sulphoxide-induced HL-60 leukaemia cells.

37. Tissue-specific expansion of uridine pools in mice. Effects of benzylacyclouridine, dipyridamole and exogenous uridine.

38. A phase II trial of cyclosporin A in the treatment of refractory metastatic colorectal cancer.

39. Induction of the differentiation of HL-60 cells by phorbol 12-myristate 13-acetate activates a Na(+)-dependent uridine-transport system. Involvement of protein kinase C.

41. Effects of uridine on the growth and differentiation of HL-60 leukemia cells.

42. Bradykinin and its Gly6 analogue are substrates of cyclophilin: a fluorine-19 magnetization transfer study.

44. Structural elements pertinent to the interaction of cyclosporin A with its specific receptor protein, cyclophilin.

45. Cyclophilin binding: a receptor-mediated approach to monitoring cyclosporine immunosuppressive activity following organ transplantation.

46. 1H NMR studies on bovine cyclophilin: preliminary structural characterization of its complex with cyclosporin A.

47. Effect of herpes simplex virus type 1 infection on nucleoside transport in HeLa S3 cells.

48. Benzylacyclouridine. Pharmacokinetics, metabolism and biochemical effects in mice.

49. Structure of peptide from active site region of Escherichia coli L-asparaginase.

50. The active site of L-asparaginase: dimethylsulfoxide effect of 5-diazo-4-oxo-L-norvaline interactions.